WORCESTER, Mass., June 9, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentations on the technologies and products under development at its wholly owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com). The presentations were made at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois on June 7 (www.asco.org) and at the Seventh World Congress on Vaccines, Immunization and Immunotherapy (WCVII) in Berlin, Germany on May 28.
